Santen Pharmaceutical. (SNPHF) Q3 2026 Earnings

6AugConfirmed
Q4 2025
Q1 2026
Q2 2026
Q3 2026
0.13
0.19
0.24
0.3

Details

Expected EPS
0.130766829193
Actual EPS
0.13761462
Surprise EPS
0.01
Surprise Percent
+5.24%

Description

Santen Pharmaceutical. (SNPHF) has reported earnings of 0.13761462 per share for Q3 2026.

0 Comments

Share your thoughts